Exact Mass: 340.2014

Exact Mass Matches: 340.2014

Found 7 metabolites which its exact mass value is equals to given mass value 340.2014, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-[(3-Methylphenyl)amino]pyrimidine-5-Carboxamide

2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-[(3-Methylphenyl)amino]pyrimidine-5-Carboxamide

C18H24N6O (340.2011)


   

Pexacerfont

N-(butan-2-yl)-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine

C18H24N6O (340.2011)


   

1-[4-(4-methylcyclohexyl)cyclohexyl]-4-(trifluoromethoxy)benzene

1-[4-(4-methylcyclohexyl)cyclohexyl]-4-(trifluoromethoxy)benzene

C20H27F3O (340.2014)


   

(2R,5S)-rel-Tetrahydro-5-propyl-2-[trans-4-(3,4,5-trifluorophenyl)cyclohexyl]-2H-pyran

(2R,5S)-rel-Tetrahydro-5-propyl-2-[trans-4-(3,4,5-trifluorophenyl)cyclohexyl]-2H-pyran

C20H27F3O (340.2014)


   

Pexacerfont

Pexacerfont

C18H24N6O (340.2011)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Bohemine

Bohemine

C18H24N6O (340.2011)


Bohemine is a purine analogue and is a synthetic and selective CDK inhibitor with IC50s of 4.6 μM, 83 μM, and 2.7 μM for Cdk2/cyclin E, Cdk2/cyclin A, and Cdk9/cyclin T1, respectively. Bohemine also inhibits ERK2 with an IC50 of 52 μM and has less inhibitory effect on CDK1, CDK4 and CDK6. Bohemine has a broad spectrum anti-cancer activities[1][2].

   

1-{(E)-amino[(4,6-dimethylquinazolin-2-yl)amino]methylidene}-3-cyclohexylurea

1-{(E)-amino[(4,6-dimethylquinazolin-2-yl)amino]methylidene}-3-cyclohexylurea

C18H24N6O (340.2011)